All Aboard! Don't Miss the Tricuspid Train

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mark Slaughter, MD
Disclosure(s): Medtronic: Advisory Board (Ongoing)

Kendra Grubb, MD, MHA, FACC
Disclosure(s): Medtronic: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); , Medtronic, Edwards, Boston Scientific, Abbott: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)

Alison Ward, MD

Presentations

  1. Outcomes of Tricuspid Valve Surgery: A single-center experience of over 1,000 patients
    Sarah Yousef, MD
     
  2. Tricuspid Valve Repair Techniques
    Matthew Romano, MD
     
  3. TRILUMINATE and Other Tricuspid Trials
    Gorav Ailawadi, MD, MBA
    Disclosure(s): edwards, Abbott, Anteris, Nyra, Medtronic, Arthrex, J&J, Philips: Advisory Board (Ongoing), Consultant (Ongoing)
     
  4. The Future of Triscupid Valve Treatment
    Vinod H. Thourani, MD
    Disclosure(s): Abbott Vascular: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AtriCure: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Advisory Board (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  5. STS Consensus Statement on the Surgical Management of Tricuspid Endocarditis in Patients who Inject Drugs
    Joshua Goldberg, MD
     
  6. A Paradigm Shift in the Treatment of Isolated Tricuspid Valve Endocarditis: The Endo-First Approach
    Hiroki A. Ueyama, MD
Activity summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Rating: 
5

Available Credit

  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mark Slaughter, MD
Disclosure(s): Medtronic: Advisory Board (Ongoing)

Kendra Grubb, MD, MHA, FACC
Disclosure(s): Medtronic: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); , Medtronic, Edwards, Boston Scientific, Abbott: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)

Alison Ward, MD

Presentations

  1. Outcomes of Tricuspid Valve Surgery: A single-center experience of over 1,000 patients
    Sarah Yousef, MD
     
  2. Tricuspid Valve Repair Techniques
    Matthew Romano, MD
     
  3. TRILUMINATE and Other Tricuspid Trials
    Gorav Ailawadi, MD, MBA
    Disclosure(s): edwards, Abbott, Anteris, Nyra, Medtronic, Arthrex, J&J, Philips: Advisory Board (Ongoing), Consultant (Ongoing)
     
  4. The Future of Triscupid Valve Treatment
    Vinod H. Thourani, MD
    Disclosure(s): Abbott Vascular: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AtriCure: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Advisory Board (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  5. STS Consensus Statement on the Surgical Management of Tricuspid Endocarditis in Patients who Inject Drugs
    Joshua Goldberg, MD
     
  6. A Paradigm Shift in the Treatment of Isolated Tricuspid Valve Endocarditis: The Endo-First Approach
    Hiroki A. Ueyama, MD